Eradication therapy may decrease the risk of immune thrombocytopenia after Helicobacter pylori infection: a retrospective cohort study in Taiwan

Eradication therapy may decrease the risk of immune thrombocytopenia after Helicobacter pylori infection: a retrospective cohort study in Taiwan

Abstract Background Helicobacter pylori (HP) eradication therapy (HPE) is recommended for patients with unexplained immune thrombocytopenia (ITP); however, the role of HPE in preventing ITP in patients with HP infection remains unclear. Therefore, this study was designed to clarify it. Methods This...

Full description

Bibliographic Details
Main Authors: Mitsuhiro Koseki, Ming‑Jen Sheu, Kang-Ting Tsai, Chung-Han Ho, Hsiao-Hua Liu, Hung-Jung Lin, Chien-Liang Lin, Chien-Cheng Huang
Format: Article
Language:English
Published: BMC 2023-02-01
Series:BMC Gastroenterology
Subjects:
Adult
Cohort study
Eradication therapy
Helicobacter pylori
Immune thrombocytopenia
Online Access:https://doi.org/10.1186/s12876-023-02664-z

Internet

https://doi.org/10.1186/s12876-023-02664-z

Similar Items